info@invisionmedi.com
GLAMOR-P Tablets
Fight Diabetes by Improving the Good Cholesterol
COMPOSITION – Glimepiride IP 2 mg + Pioglitazone Hydrochloride 15 mg Tabs.
Description
Diabetes is a strong, independent risk factor for cardiovascular disease, causing a 2- to 4-fold increase in cardiovascular mortality in patients with T2D.
Type 2 diabetes mellitus is characterized by insulin resistance and progressive β cell failure; therefore, β cell secretagogues are useful for achieving sufficient glycemic control.
Glimepiride
- Drug class: Sulfonylureas
- Glimepiride lowers blood glucose by stimulating pancreatic β cells to release insulin.
- Shows a significant decrease in triglycerides and an increase in high-density lipoprotein.
- Induces PPAR gamma activity, thereby improving insulin resistance.
Pioglitazone
- Drug class: Thiazolidinediones
Pioglitazone HCl
- Pioglitazone hydrochloride, a thiazolidinedione compound, is a new therapeutic agent for the treatment of type 2 diabetes that reduces insulin resistance by enhancing insulin action in skeletal muscle, liver, and adipose tissue.
- Pioglitazone HCL is a PPAR-γ agonist that increases insulin-stimulated glucose uptake in peripheral tissues.
Combination
In a study of the long-term effect of TZD, the combination was associated with significantly reduced plasma lipoprotein (a) levels, a known risk factor for cardiovascular disease, compared with the rosiglitazone combination
Composition
Glimepiride IP 2 mg + Pioglitazone Hydrochloride 15 mg Tabs.
Related products
-
V-BOSE-GM2 – Tablets
An Abiding Antidiabetic combination for coherent Diabetic Control COMPOSITION – Glimepiride IP 2 mg+ Voglibose 0.2 mg + Metformin Hydrochloride IP 500 mg (SR)
-
SAXAGEN-M 500 SR Tablets
Next Generation Anti-diabetic COMPOSITION – Saxagliptin 5 mg + Metformin HCI 500 mg ER (Extended Release)
-
ZIVALIO-10 Tablets
A Revolutionary Therapy to Control the Menace of T2DM COMPOSITION – Dapagliflozin 10 mg
-
TENLIFAST-M 500SR / 1000SR Tablets
Prevent Diabetic Complications & Acquire Functional Hemodynamic Indices COMPOSITION – Teneligliptin Hydrobromide Hydrate eq. to Teneligliptin 20 mg + Metformin Hydrochloride IP 500 mg (SR) Teneligliptin Hydrobromide Hydrate eq. to Teneligliptin 20 mg + Metformin Hydrochloride IP 1000 mg (SR)